Recovered from Past Hepatitis B Infection with Immunity
Your serologic pattern indicates that you have recovered from a past hepatitis B infection and now have immunity. 1
What Your Results Mean
Your specific serologic profile shows:
- HBsAg (Hepatitis B surface antigen): Non-reactive - No active infection
- Anti-HBc (Hepatitis B core antibody): Reactive - Evidence of past exposure to HBV
- Anti-HBe (Hepatitis B e antibody): Reactive - Indicates loss of replicating virus
- Anti-HBs: Reactive (implied by the pattern) - Protective immunity developed
- IgM anti-HBc: Non-reactive - Not acute infection
- HBeAg: Non-reactive - No active viral replication
According to CDC guidelines, when HBsAg is negative, total anti-HBc is positive, and anti-HBs is positive, this indicates "Recovered from past infection and immune" 1, 2. This is the classic serologic pattern of resolved HBV infection with natural immunity.
Clinical Significance
You are not currently infected and are immune to future HBV infection. 3
The presence of anti-HBc distinguishes natural immunity (from past infection) from vaccine-induced immunity. Persons who respond to hepatitis B vaccine are positive only for anti-HBs, whereas persons who recover from natural HBV infection are typically positive for both anti-HBs and anti-HBc 1.
The reactive anti-HBe in your case further supports that you had past infection with subsequent viral clearance, as anti-HBe correlates with the loss of replicating virus 1.
What You Need to Know
- You are not infectious - You cannot transmit hepatitis B to others
- You have protective immunity - You are protected against future HBV infection
- No treatment needed - No antiviral therapy or monitoring is required
- No vaccination needed - You already have natural immunity that is typically lifelong 3
Important Caveat
If you ever require immunosuppressive therapy or chemotherapy in the future, inform your physician about this serologic pattern. While rare, HBV reactivation can occur in persons who are HBsAg-negative and anti-HBc-positive during immunosuppression, with reappearance of HBsAg 1. In such situations, prophylactic antiviral therapy may be considered depending on the type and intensity of immunosuppression 4.